Morgan Stanley’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.48B | Sell |
|
|||||
|
2025
Q1 | $1.65B | Buy |
|
|||||
|
2024
Q4 | $1.28B | Buy |
|
|||||
|
2024
Q3 | $1.41B | Sell |
|
|||||
|
2024
Q2 | $1.53B | Buy |
|
|||||
|
2024
Q1 | $1.33B | Sell |
|
|||||
|
2023
Q4 | $2.43B | Buy |
|
|||||
|
2023
Q3 | $998M | Buy |
|
|||||
|
2023
Q2 | $979M | Buy |
|
|||||
|
2023
Q1 | $741M | Sell |
|
|||||
|
2022
Q4 | $745M | Buy |
|
|||||
|
2022
Q3 | $561M | Buy |
|
|||||
|
2022
Q2 | $515M | Buy |
|
|||||
|
2022
Q1 | $216M | Sell |
|
|||||
|
2021
Q4 | $213M | Sell |
|
|||||
|
2021
Q3 | $189M | Sell |
|
|||||
|
2021
Q2 | $246M | Buy |
|
|||||
|
2021
Q1 | $192M | Sell |
|
|||||
|
2020
Q4 | $217M | Buy |
|
|||||
|
2020
Q3 | $210M | Buy |
|
|||||
|
2020
Q2 | $200M | Buy |
|
|||||
|
2020
Q1 | $161M | Sell |
|
|||||
|
2019
Q4 | $169M | Buy |
|
|||||
|
2019
Q3 | $95.9M | Buy |
|
|||||
|
2019
Q2 | $101M | Buy |
|
|||||
|
2019
Q1 | $94.1M | Sell |
|
|||||
|
2018
Q4 | $124M | Buy |
|
|||||
|
2018
Q3 | $133M | Buy |
|
|||||
|
2018
Q2 | $106M | Sell |
|
|||||
|
2018
Q1 | $129M | Sell |
|
|||||
|
2017
Q4 | $194M | Buy |
|
|||||
|
2017
Q3 | $127M | Sell |
|
|||||
|
2017
Q2 | $214M | Buy |
|
|||||
|
2017
Q1 | $66.1M | Buy |
|
|||||
|
2016
Q4 | $20.5M | Sell |
|
|||||
|
2016
Q3 | $63.3M | Buy |
|
|||||
|
2016
Q2 | $16.9M | Sell |
|
|||||
|
2016
Q1 | $28.5M | Buy |
|
|||||
|
2015
Q4 | $39M | Buy |
|
|||||
|
2015
Q3 | $20.6M | Buy |
|
|||||
|
2015
Q2 | $24.3M | Sell |
|
|||||
|
2015
Q1 | $25.1M | Sell |
|
|||||
|
2014
Q4 | $33.7M | Buy |
|
|||||
|
2014
Q3 | $28.9M | Sell |
|
|||||
|
2014
Q2 | $37M | Buy |
|
|||||
|
2014
Q1 | $13.2M | Sell |
|
|||||
|
2013
Q4 | $19M | Sell |
|
|||||
|
2013
Q3 | $29.5M | Buy |
|
|||||
|
2013
Q2 | $22.3M | Buy |
|